Automata Technologies Forms Advisory Board of Senior Life Sciences Executives

Automata Technologies, a leading automation company driving automation in life science laboratories, has established its first advisory board, comprised of top executives from the healthcare and life sciences industries. The role of the board will be to advise the board and Automata management team on commercialization strategy and provide key industry insights and guidance in each of its target sub-sectors.

The appointment comes after Automata Technologies raised $40 million in a funding round last October led by Dimension Capital with participation from AP Moller Holding, parent company of AP Moller Group and owners of, among others, laboratory testing group Unilabs. Joe Stringer, a healthcare investor and industry specialist, was also named executive chairman of Automata and Director of Corporate Development (EMEA) in November, which initiated Automata’s expansion efforts.

The advisory board will include Dr Sy Pretorius, former marketing director at Parexel and currently chief operating officer of US outsourcing company Eversana, former chairman of NHS England, Lord Prior of Brampton, and senior leader of the biotechnology department, Dr Annalisa Jenkins.

The board members span both the private and public sectors and include senior leaders from pharmaceutical, healthcare, regulatory affairs, research and international trade. The ambition of this board is to guide Automata on its journey to make automation technologies accessible to all laboratories seeking to develop and deliver life-changing treatments to patients faster.

Attracting such an impressive group of senior advisors from our key business sectors: healthcare, biotech, pharmaceuticals and outsourcing is a great validation of the value of Automata and the potential our technology can unlock for the industry.

These experienced industry players will provide invaluable insight and advice as we continue to accelerate our growth and industry presence, ultimately helping to solve the challenges facing life science laboratories today.”

Mostafa Elsayed, Co-Founder and CEO, Automata